Lavaca Capital LLC Organon & Co. Transaction History

Lavaca Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $280,261 - $362,269	-9,204 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $3,383 - $4,381	-118 Reduced 1.27%	9,204 $280,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $42,315 - $52,675	-1,478 Reduced 13.69%	9,322 $306,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $307,260 - $410,400	10,800 New	10,800 $327,000

793

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.71B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Lavaca Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Lavaca Capital LLC with notifications on news.